Company intelligence / Profile preview
INOVIQ
Notting Hill, VIC, Australia
- Ownership
- Private
- Employees
- ~20
- Development stage
- Commercial
01
Overview
INOVIQ has commercialized the EXO-NET® exosome isolation tool and the hTERT test as an adjunct to urine cytology in bladder cancer. Its pipeline includes clinical-stage blood tests for early detection/monitoring of ovarian and breast cancers, with ongoing development of exosome-based therapeutics in preclinical stages targeting solid tumors. The company has secured global distribution partnerships and expanded its IP portfolio around exosome capture/isolation technologies.
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic test (for diagnostics)Exosome-based therapy (for therapeutics)
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Promega Corporation – global supply/distribution agreement for EXO-NET® productsResearchDx – license/supply agreement in US market
Beyond the preview
Go deeper on INOVIQ.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on INOVIQ.